Endo Pharmaceuticals is a specialty pharmaceutical company with an established leadership in pain management. Endo Pharmaceuticals focuses on the research, development and marketing of prescription pharmaceuticals used primarily to treat and manage pain.
Endo Pharmaceuticals has entered into a license and development agreement with Alexza for the exclusive clinical development and commercialization rights in North America for Alexza's AZ-003 (Staccato fentanyl for the treatment of breakthrough pain in cancer and non-cancer patients.
Symphony Allegro, Inc.
Symphony Allegro, Inc. is a biopharmaceutical company collaborating with Alexza on the clinical development of three of our leading pipeline candidates.
Symphony Allegro is supporting the advancement of AZ-004 through Phase III clinical trials for the treatment of acute agitation in patients with schizophrenia and bipolar disorder, AZ-104 through Phase IIa clinical trials for the treatment of migraine, and AZ-002 through Phase IIb clinical trials for the treatment of panic attack in patients with panic disorder.
Autoliv ASP, Inc.
Autoliv ASP, Inc., the North American subsidiary of Sweden-based Autoliv Inc., is a leader in the design and manufacture of energetic materials for state-of-the-art automotive safety systems. Through a unique partnering agreement, Autoliv ASP inc. will manufacture the chemical heat packages for the single-dose Staccato system.
Alexza Singapore Pte, Ltd.
In March 2008, we established Alexza Singapore Pte. Ltd. to oversee the establishment of our manufacturing company in Singapore to provide lower housing assemblies for our single-dose Staccato system.